Received Sep 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | H4K3S | IM / LA |
Patient feels fine with no adverse effects. Patient received another dose of Tdap in 07/14/2025. This dose was not appropriate for patient.
N/A
N/A
N/A
Etodolac, NSAIDS, Phenothiazines, Piperazine and Piperazine salts, and sulfur dioxide